GOSURANEMAB
UNII 09FZ7Q0PQZ

Substance Identification & Data

This profile provides standardized clinical and technical data for Gosuranemab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 09FZ7Q0PQZ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1788032-39-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

09FZ7Q0PQZ

CAS Registry Number

1788032-39-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

GOSURANEMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C175078

National Cancer Institute reference terminology for clinical and research data.

INN ID

10663

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

DE-69

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Gosuranemab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

GOSURANEMAB

Common Names & Synonyms

ANTI-ETAU HUMANIZED IGG4 MONOCLONAL ANTIBODY

ANTI-EXTRACELLULAR TAU HUMANIZED IGG4 MONOCLONAL ANTIBODY

GOSURANEMAB [INN]

GOSURANEMAB [JAN]

GOSURANEMAB [USAN]

IMMUNOGLOBULIN G4, ANTI-(HUMAN TAU PROTEIN) (HUMAN-MUS MUSCULUS MONOCLONAL BMS-986168 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL BMS-986168 LIGHT CHAIN, DIMER